*Dexcom, Inc. was featured during Mayor Giles' 2019 State of the City, see the video at https://youtu.be/XKUJqb9E3yo
Dexcom, Inc., a leader in continuous glucose monitoring for patients with diabetes, recently announced an expansion in southeast Mesa. The new lease at Landing 202 is 486,000 square feet and adds a facility to their portfolio that is three times the size of their west Mesa location. The new Mesa Regional Distribution Center is designed to grow with the company.
"Dexcom chose to expand here in Mesa and really hasn't stopped since they arrived," Mayor John Giles said. "Their innovative approach to continuous glucose monitoring makes them an industry leader and I'm proud of their success in our city."
Dexcom has rapidly increased production since opening in Mesa just three years ago. This expansion will allow their workforce to reach more than 1,000 employees. Landing 202 is an ideal location with easy freeway access and proximity to communities like Eastmark and Cadence.
The building will include Dexcom's Logistics and Distribution and Quality Assurance Receiving and Inspection operations. Initial occupancy is expected in spring 2021.
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information visit www.dexcom.com.
About Landing 202:
Landing 202 is a 605,000-square-foot Class A industrial product on approximately 45 acres just south of Loop 202 and west of Hawes Road on the north side of Ray Road in Mesa's Gateway Area. It is within one of Mesa's federally designated opportunity zones, which allow investors to defer and potentially reduce taxes on capital gains, so long as the gain is reinvested in a qualified opportunity fund that invests in a qualified opportunity zone.
Contact: Melissa Randazzo